Announcements Trials
Browse Landscape

Status

Recruiting 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms, Second Primary 1

Interventions

Surveys and Questionnaires 39Blood Specimen Collection 23Specimen Handling 14Radiotherapy 12Surgical Procedures, Operative 10Magnetic Resonance Spectroscopy 10Interviews as Topic 10Observation 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Immune Checkpoint Inhibitors 5Biopsy 5ribociclib 4palbociclib 4lorlatinib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Magnetic Resonance Imaging 4Ipilimumab 4High-Throughput Nucleotide Sequencing 4Hepatectomy 4Echocardiography 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Anthracyclines × Clear all
NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting
20 enrolled
Tumor-Agnostic

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡